KIMIDESS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kimidess, and when can generic versions of Kimidess launch?
Kimidess is a drug marketed by Ph Health and is included in one NDA.
The generic ingredient in KIMIDESS is desogestrel; ethinyl estradiol. There is one drug master file entry for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kimidess
A generic version of KIMIDESS was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12th, 1999.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KIMIDESS?
- What are the global sales for KIMIDESS?
- What is Average Wholesale Price for KIMIDESS?
Summary for KIMIDESS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Patent Applications: | 455 |
| Drug Prices: | Drug price information for KIMIDESS |
| DailyMed Link: | KIMIDESS at DailyMed |
US Patents and Regulatory Information for KIMIDESS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ph Health | KIMIDESS | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 076681-001 | Apr 30, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
